Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases

Cijo George Vazhappilly, Shabbir Ahmed Ansari, Rula Al-Jaleeli, Aya Mudhafar Al-Azawi, Wafaa S. Ramadan, Varsha Menon, Rawad Hodeify, Shoib Sarwar Siddiqui, Maxime Merheb, Rachel Matar, Rajan Radhakrishnan

Research output: Contribution to journalReview article

Abstract

The failure of mechanisms of natural anti-coagulation either due to genetic impairment or due to severe external injuries may result in a condition called thrombosis. This is believed to be the primary cause for a variety of life-threatening conditions such as: heart attack, stroke, pulmonary embolism, thrombophlebitis, and deep venous thrombosis (DVT). The growing number of these incidents requires an alternative anti-coagulant or anti-thrombotic agent that has minimal side effects and improved efficiency. For decades, plant polyphenols, especially flavonoids, were known for their vital role in preventing various diseases such as cancer. Mitigating excessive oxidative stress caused by reactive oxygen species (ROS) with anti-oxidant-rich flavonoids may reduce the risk of hyper-activation of platelets, cardiovascular diseases (CVD), pain, and thrombosis. Furthermore, flavonoids may mitigate endothelial dysfunction (ED), which generally correlates to the development of coronary artery and vascular diseases. Flavonoids also reduce the risk of atherosclerosis and atherothrombotic disease by inhibiting excessive tissue factor (TF) availability in the endothelium. Although the role of flavonoids in CVD is widely discussed, to the best of our knowledge, their role as anti-thrombotic lead has not been discussed. This review aims to focus on the biological uses of dietary flavonoids and their role in the treatment of various coagulation disorders, and may provide some potential lead to the drug discovery process in this area.

Original languageEnglish
JournalInflammopharmacology
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Flavonoids
Cardiovascular Diseases
Thrombosis
Coagulants
Thrombophlebitis
Platelet Activation
Thromboplastin
Polyphenols
Drug Discovery
Pulmonary Embolism
Vascular Diseases
Oxidants
Venous Thrombosis
Endothelium
Coronary Artery Disease
Reactive Oxygen Species
Atherosclerosis
Oxidative Stress
Stroke
Myocardial Infarction

Keywords

  • Cardiovascular diseases
  • Flavonoids
  • Reactive oxygen species
  • Thrombosis
  • Tissue factor

ASJC Scopus subject areas

  • Immunology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Vazhappilly, C. G., Ansari, S. A., Al-Jaleeli, R., Al-Azawi, A. M., Ramadan, W. S., Menon, V., ... Radhakrishnan, R. (2019). Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases. Inflammopharmacology. https://doi.org/10.1007/s10787-019-00612-6

Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases. / Vazhappilly, Cijo George; Ansari, Shabbir Ahmed; Al-Jaleeli, Rula; Al-Azawi, Aya Mudhafar; Ramadan, Wafaa S.; Menon, Varsha; Hodeify, Rawad; Siddiqui, Shoib Sarwar; Merheb, Maxime; Matar, Rachel; Radhakrishnan, Rajan.

In: Inflammopharmacology, 01.01.2019.

Research output: Contribution to journalReview article

Vazhappilly, CG, Ansari, SA, Al-Jaleeli, R, Al-Azawi, AM, Ramadan, WS, Menon, V, Hodeify, R, Siddiqui, SS, Merheb, M, Matar, R & Radhakrishnan, R 2019, 'Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases', Inflammopharmacology. https://doi.org/10.1007/s10787-019-00612-6
Vazhappilly CG, Ansari SA, Al-Jaleeli R, Al-Azawi AM, Ramadan WS, Menon V et al. Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases. Inflammopharmacology. 2019 Jan 1. https://doi.org/10.1007/s10787-019-00612-6
Vazhappilly, Cijo George ; Ansari, Shabbir Ahmed ; Al-Jaleeli, Rula ; Al-Azawi, Aya Mudhafar ; Ramadan, Wafaa S. ; Menon, Varsha ; Hodeify, Rawad ; Siddiqui, Shoib Sarwar ; Merheb, Maxime ; Matar, Rachel ; Radhakrishnan, Rajan. / Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases. In: Inflammopharmacology. 2019.
@article{995f4f01a947406ba45f8bd06d1e0d07,
title = "Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases",
abstract = "The failure of mechanisms of natural anti-coagulation either due to genetic impairment or due to severe external injuries may result in a condition called thrombosis. This is believed to be the primary cause for a variety of life-threatening conditions such as: heart attack, stroke, pulmonary embolism, thrombophlebitis, and deep venous thrombosis (DVT). The growing number of these incidents requires an alternative anti-coagulant or anti-thrombotic agent that has minimal side effects and improved efficiency. For decades, plant polyphenols, especially flavonoids, were known for their vital role in preventing various diseases such as cancer. Mitigating excessive oxidative stress caused by reactive oxygen species (ROS) with anti-oxidant-rich flavonoids may reduce the risk of hyper-activation of platelets, cardiovascular diseases (CVD), pain, and thrombosis. Furthermore, flavonoids may mitigate endothelial dysfunction (ED), which generally correlates to the development of coronary artery and vascular diseases. Flavonoids also reduce the risk of atherosclerosis and atherothrombotic disease by inhibiting excessive tissue factor (TF) availability in the endothelium. Although the role of flavonoids in CVD is widely discussed, to the best of our knowledge, their role as anti-thrombotic lead has not been discussed. This review aims to focus on the biological uses of dietary flavonoids and their role in the treatment of various coagulation disorders, and may provide some potential lead to the drug discovery process in this area.",
keywords = "Cardiovascular diseases, Flavonoids, Reactive oxygen species, Thrombosis, Tissue factor",
author = "Vazhappilly, {Cijo George} and Ansari, {Shabbir Ahmed} and Rula Al-Jaleeli and Al-Azawi, {Aya Mudhafar} and Ramadan, {Wafaa S.} and Varsha Menon and Rawad Hodeify and Siddiqui, {Shoib Sarwar} and Maxime Merheb and Rachel Matar and Rajan Radhakrishnan",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s10787-019-00612-6",
language = "English",
journal = "Inflammopharmacology",
issn = "0925-4692",
publisher = "Birkhauser Verlag Basel",

}

TY - JOUR

T1 - Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases

AU - Vazhappilly, Cijo George

AU - Ansari, Shabbir Ahmed

AU - Al-Jaleeli, Rula

AU - Al-Azawi, Aya Mudhafar

AU - Ramadan, Wafaa S.

AU - Menon, Varsha

AU - Hodeify, Rawad

AU - Siddiqui, Shoib Sarwar

AU - Merheb, Maxime

AU - Matar, Rachel

AU - Radhakrishnan, Rajan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The failure of mechanisms of natural anti-coagulation either due to genetic impairment or due to severe external injuries may result in a condition called thrombosis. This is believed to be the primary cause for a variety of life-threatening conditions such as: heart attack, stroke, pulmonary embolism, thrombophlebitis, and deep venous thrombosis (DVT). The growing number of these incidents requires an alternative anti-coagulant or anti-thrombotic agent that has minimal side effects and improved efficiency. For decades, plant polyphenols, especially flavonoids, were known for their vital role in preventing various diseases such as cancer. Mitigating excessive oxidative stress caused by reactive oxygen species (ROS) with anti-oxidant-rich flavonoids may reduce the risk of hyper-activation of platelets, cardiovascular diseases (CVD), pain, and thrombosis. Furthermore, flavonoids may mitigate endothelial dysfunction (ED), which generally correlates to the development of coronary artery and vascular diseases. Flavonoids also reduce the risk of atherosclerosis and atherothrombotic disease by inhibiting excessive tissue factor (TF) availability in the endothelium. Although the role of flavonoids in CVD is widely discussed, to the best of our knowledge, their role as anti-thrombotic lead has not been discussed. This review aims to focus on the biological uses of dietary flavonoids and their role in the treatment of various coagulation disorders, and may provide some potential lead to the drug discovery process in this area.

AB - The failure of mechanisms of natural anti-coagulation either due to genetic impairment or due to severe external injuries may result in a condition called thrombosis. This is believed to be the primary cause for a variety of life-threatening conditions such as: heart attack, stroke, pulmonary embolism, thrombophlebitis, and deep venous thrombosis (DVT). The growing number of these incidents requires an alternative anti-coagulant or anti-thrombotic agent that has minimal side effects and improved efficiency. For decades, plant polyphenols, especially flavonoids, were known for their vital role in preventing various diseases such as cancer. Mitigating excessive oxidative stress caused by reactive oxygen species (ROS) with anti-oxidant-rich flavonoids may reduce the risk of hyper-activation of platelets, cardiovascular diseases (CVD), pain, and thrombosis. Furthermore, flavonoids may mitigate endothelial dysfunction (ED), which generally correlates to the development of coronary artery and vascular diseases. Flavonoids also reduce the risk of atherosclerosis and atherothrombotic disease by inhibiting excessive tissue factor (TF) availability in the endothelium. Although the role of flavonoids in CVD is widely discussed, to the best of our knowledge, their role as anti-thrombotic lead has not been discussed. This review aims to focus on the biological uses of dietary flavonoids and their role in the treatment of various coagulation disorders, and may provide some potential lead to the drug discovery process in this area.

KW - Cardiovascular diseases

KW - Flavonoids

KW - Reactive oxygen species

KW - Thrombosis

KW - Tissue factor

UR - http://www.scopus.com/inward/record.url?scp=85068973409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068973409&partnerID=8YFLogxK

U2 - 10.1007/s10787-019-00612-6

DO - 10.1007/s10787-019-00612-6

M3 - Review article

AN - SCOPUS:85068973409

JO - Inflammopharmacology

JF - Inflammopharmacology

SN - 0925-4692

ER -